Peringatan Keamanan

Oral LD50 is 185 mg/kg in rats.L42780

Due to its actions on opioid receptors, loperamide has been misused and abused to self-manage opioid withdrawal symptoms and to induce euphoria.A251610, A251625 However, loperamide is associated with a risk of experiencing a range of adverse effects, often life-threatening, if taken for non-therapeutic reasons or at doses higher than the recommended dose.L42790 Loperamide overdose can lead to a range of cardiac and non-cardiac effects. Chronic ingestion of doses ranging from 70 mg to 1600 mg daily - which is four to 100 times the recommended dose - resulted in life-threatening cardiac adverse reactions, including QT/QTc and QRS interval prolongation, Torsades de Pointes, Brugada syndrome and other ventricular arrhythmias, syncope, cardiac arrest, and death. These cases included instances of loperamide misuse and abuse. In case of cardiac effects, it is recommended that loperamide is discontinued and therapies to manage and prevent cardiac arrhythmias are initiated.L42790 Cases of loperamide overdose may cause opioid toxic effects including CNS depression (e.g. altered mental status, stupor, coordination disorders, somnolence, miosis, muscular hypertonia, respiratory depression), hypotension, urinary retention, and paralytic ileus.L42790 Naloxone may reverse the opioid-related toxicity, including CNS and respiratory depression, and hypotension, associated with loperamide overdosage.L42790

Loperamide

DB00836

small molecule approved

Deskripsi

Loperamide is an anti-diarrheal agent that is available as an over-the-counter product for treating diarrhea.L42785 The drug was first synthesized in 1969 and used medically in 1976.A251610 It is a highly lipophilic synthetic phenylpiperidine opioid that works by binding to mu-opioid receptors on intestinal muscles to decrease intestinal motility and electrolyte loss.A251610 Loperamide has a chemical structure that is similar to diphenoxylate and haloperidol;A6249 however, loperamide works on mu (?)-opioid receptors to mediate its pharmacological actions.A251610

Struktur Molekul 2D

Berat 477.038
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.[L42790]
Volume Distribusi Loperamide has a large volume of distribution.[A251610] Although highly lipophilic, loperamide does not cross the blood-brain barrier [A6249] and generally acts peripherally.[A251615]
Klirens (Clearance) -

Absorpsi

Loperamide is well absorbed from the gastrointestinal tract; however, it undergoes extensive first-pass metabolism to form metabolites that are excreted in the bile. Therefore, little loperamide actually reaches the systemic circulation.A251615 The drug bioavailability is less than 1%.A251610 Following oral administration of a 2 mg capsule of loperamide, plasma concentrations of unchanged drug were below 2 ng/mL. Plasma loperamide concentrations are highest approximately five hours after administration of an oral capsule of loperamide and 2.5 hours after the liquid formulation of the drug.L42790

Metabolisme

Loperamide is extensively metabolized. The primary metabolic pathway is oxidative N-demethylation mediated by CYP2C8 and CYP3A4, to form N-demethyl loperamide. CYP2B6 and CYP2D6 play a minor role in loperamide N-demethylation.L42790 Metabolites of loperamide are pharmacologically inactive.A251625

Rute Eliminasi

Loperamide and its metabolites in the systemic circulation undergo biliary excretion.A251625 Excretion of the unchanged loperamide and its metabolites mainly occurs through the feces.L42790 Only 1% of an absorbed dose excreted unchanged in the urine.A251625

Interaksi Obat

998 Data
Ceritinib Loperamide may increase the bradycardic activities of Ceritinib.
Ivabradine Loperamide may increase the bradycardic activities of Ivabradine.
Eliglustat The serum concentration of Loperamide can be increased when it is combined with Eliglustat.
Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Loperamide.
Colchicine The serum concentration of Colchicine can be increased when it is combined with Loperamide.
Fentanyl Fentanyl may increase the bradycardic activities of Loperamide.
Iloperidone The risk or severity of QTc prolongation can be increased when Loperamide is combined with Iloperidone.
Tofacitinib Loperamide may increase the bradycardic activities of Tofacitinib.
Vardenafil The excretion of Loperamide can be decreased when combined with Vardenafil.
Cimetidine The metabolism of Loperamide can be decreased when combined with Cimetidine.
Clopidogrel The metabolism of Loperamide can be decreased when combined with Clopidogrel.
Efavirenz The metabolism of Loperamide can be decreased when combined with Efavirenz.
Dantrolene The risk or severity of hyperkalemia can be increased when Loperamide is combined with Dantrolene.
Mifepristone The serum concentration of Loperamide can be increased when it is combined with Mifepristone.
Tacrolimus The excretion of Loperamide can be decreased when combined with Tacrolimus.
Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Loperamide.
Mirabegron The excretion of Loperamide can be decreased when combined with Mirabegron.
Boceprevir The metabolism of Loperamide can be decreased when combined with Boceprevir.
Carteolol Loperamide may increase the arrhythmogenic activities of Carteolol.
Tocainide Loperamide may increase the arrhythmogenic activities of Tocainide.
Metipranolol Loperamide may increase the arrhythmogenic activities of Metipranolol.
Xylometazoline Loperamide may increase the arrhythmogenic activities of Xylometazoline.
Fasudil Loperamide may increase the arrhythmogenic activities of Fasudil.
Tropisetron Loperamide may increase the arrhythmogenic activities of Tropisetron.
Spiradoline Loperamide may increase the arrhythmogenic activities of Spiradoline.
Tiracizine Loperamide may increase the arrhythmogenic activities of Tiracizine.
Ethacizine Loperamide may increase the arrhythmogenic activities of Ethacizine.
Hydroquinine Loperamide may increase the arrhythmogenic activities of Hydroquinine.
Bioallethrin Loperamide may increase the arrhythmogenic activities of Bioallethrin.
Fosfructose Loperamide may increase the arrhythmogenic activities of Fosfructose.
Hydroquinidine Loperamide may increase the arrhythmogenic activities of Hydroquinidine.
SOR-C13 Loperamide may increase the arrhythmogenic activities of SOR-C13.
Acetyldigitoxin Acetyldigitoxin may increase the arrhythmogenic activities of Loperamide.
Deslanoside Loperamide may increase the arrhythmogenic activities of Deslanoside.
Cymarin Loperamide may increase the arrhythmogenic activities of Cymarin.
Ibutilide Ibutilide may increase the arrhythmogenic activities of Loperamide.
Atropine Atropine may increase the arrhythmogenic activities of Loperamide.
Adenosine Adenosine may increase the arrhythmogenic activities of Loperamide.
Levosimendan Loperamide may increase the arrhythmogenic activities of Levosimendan.
Tedisamil Loperamide may increase the arrhythmogenic activities of Tedisamil.
Melperone Loperamide may increase the arrhythmogenic activities of Melperone.
Simendan Loperamide may increase the arrhythmogenic activities of Simendan.
Nizofenone Loperamide may increase the arrhythmogenic activities of Nizofenone.
Bunaftine Loperamide may increase the arrhythmogenic activities of Bunaftine.
Lorcainide Loperamide may increase the arrhythmogenic activities of Lorcainide.
Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Loperamide.
Moricizine Moricizine may increase the arrhythmogenic activities of Loperamide.
Bretylium Loperamide may increase the arrhythmogenic activities of Bretylium.
Encainide Loperamide may increase the arrhythmogenic activities of Encainide.
Ajmaline Loperamide may increase the arrhythmogenic activities of Ajmaline.
Methsuximide Loperamide may increase the arrhythmogenic activities of Methsuximide.
Vernakalant Loperamide may increase the arrhythmogenic activities of Vernakalant.
Cariporide Loperamide may increase the arrhythmogenic activities of Cariporide.
Pilsicainide Loperamide may increase the arrhythmogenic activities of Pilsicainide.
Cicletanine Loperamide may increase the arrhythmogenic activities of Cicletanine.
Cibenzoline Loperamide may increase the arrhythmogenic activities of Cibenzoline.
Prajmaline Loperamide may increase the arrhythmogenic activities of Prajmaline.
Lorajmine Loperamide may increase the arrhythmogenic activities of Lorajmine.
Lamotrigine Lamotrigine may increase the arrhythmogenic activities of Loperamide.
Nicorandil Loperamide may increase the arrhythmogenic activities of Nicorandil.
Fosinoprilat Loperamide may increase the arrhythmogenic activities of Fosinoprilat.
Digoxin Digoxin may increase the arrhythmogenic activities of Loperamide.
Metildigoxin Loperamide may increase the arrhythmogenic activities of Metildigoxin.
Acetyldigoxin Loperamide may increase the arrhythmogenic activities of Acetyldigoxin.
Sparteine Loperamide may increase the arrhythmogenic activities of Sparteine.
Aprindine Loperamide may increase the arrhythmogenic activities of Aprindine.
Procainamide Loperamide may increase the arrhythmogenic activities of Procainamide.
Flecainide Loperamide may increase the arrhythmogenic activities of Flecainide.
Ziconotide Loperamide may increase the arrhythmogenic activities of Ziconotide.
Landiolol Loperamide may increase the arrhythmogenic activities of Landiolol.
Atenolol Atenolol may increase the arrhythmogenic activities of Loperamide.
Alprenolol Loperamide may increase the arrhythmogenic activities of Alprenolol.
Pindolol Loperamide may increase the bradycardic activities of Pindolol.
Practolol Loperamide may increase the arrhythmogenic activities of Practolol.
Penbutolol Loperamide may increase the bradycardic activities of Penbutolol.
Dexpropranolol Loperamide may increase the arrhythmogenic activities of Dexpropranolol.
Bufuralol Loperamide may increase the bradycardic activities of Bufuralol.
Bopindolol Loperamide may increase the bradycardic activities of Bopindolol.
Levobetaxolol Loperamide may increase the bradycardic activities of Levobetaxolol.
Esatenolol Loperamide may increase the bradycardic activities of Esatenolol.
Cloranolol Loperamide may increase the bradycardic activities of Cloranolol.
Mepindolol Loperamide may increase the bradycardic activities of Mepindolol.
Epanolol Loperamide may increase the bradycardic activities of Epanolol.
Tertatolol Loperamide may increase the arrhythmogenic activities of Tertatolol.
Labetalol Labetalol may increase the bradycardic activities of Loperamide.
Bevantolol Loperamide may increase the bradycardic activities of Bevantolol.
Bucindolol Loperamide may increase the bradycardic activities of Bucindolol.
Betaxolol Betaxolol may increase the arrhythmogenic activities of Loperamide.
Acebutolol Loperamide may increase the arrhythmogenic activities of Acebutolol.
Oxprenolol Loperamide may increase the arrhythmogenic activities of Oxprenolol.
Indenolol Loperamide may increase the arrhythmogenic activities of Indenolol.
Esmolol Esmolol may increase the arrhythmogenic activities of Loperamide.
Celiprolol Loperamide may increase the arrhythmogenic activities of Celiprolol.
Bupranolol Loperamide may increase the arrhythmogenic activities of Bupranolol.
Talinolol Loperamide may increase the arrhythmogenic activities of Talinolol.
Anisodamine Loperamide may increase the arrhythmogenic activities of Anisodamine.
Nadolol Loperamide may increase the arrhythmogenic activities of Nadolol.
Sotalol Sotalol may increase the arrhythmogenic activities of Loperamide.
Magnesium sulfate Magnesium sulfate may increase the arrhythmogenic activities of Loperamide.
Magnesium salicylate The risk or severity of hyperkalemia can be increased when Loperamide is combined with Magnesium salicylate.

Target Protein

Mu-type opioid receptor OPRM1
Delta-type opioid receptor OPRD1
Kappa-type opioid receptor OPRK1
Pro-opiomelanocortin POMC
Voltage-dependent P/Q-type calcium channel subunit alpha-1A CACNA1A
Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2
Calmodulin CALM1

Referensi & Sumber

Synthesis reference: Tsutomu Awamura, Hisanobu Nishikawa, Toshio Inagi, "FILM PREPARATION CONTAINING LOPERAMIDE HYDROCHLORIDE." U.S. Patent US20110159058, issued June 30, 2011.
Artikel (PubMed)
  • PMID: 32491808
    Sahi N, Nguyen R, Santos C: Loperamide .
  • PMID: 18192961
    Baker DE: Loperamide: a pharmacological review. Rev Gastroenterol Disord. 2007;7 Suppl 3:S11-8.
  • PMID: 21703817
    Regnard C, Twycross R, Mihalyo M, Wilcock A: Loperamide. J Pain Symptom Manage. 2011 Aug;42(2):319-23. doi: 10.1016/j.jpainsymman.2011.06.001. Epub 2011 Jun 23.
  • PMID: 28506439
    Wu PE, Juurlink DN: Clinical Review: Loperamide Toxicity. Ann Emerg Med. 2017 Aug;70(2):245-252. doi: 10.1016/j.annemergmed.2017.04.008. Epub 2017 May 13.
  • PMID: 30189347
    Pannemans J, Corsetti M: Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders? Curr Opin Pharmacol. 2018 Dec;43:53-58. doi: 10.1016/j.coph.2018.08.008. Epub 2018 Sep 3.

Contoh Produk & Brand

Produk: 489 • International brands: 8
Produk
  • 7 Select Anti Diarrheal
    Tablet, film coated • 2 mg/1 • Oral • US • Generic • OTC • Approved
  • 7 Select Anti Diarrheal
    Solution • 1 mg/7.5mL • Oral • US • Generic • OTC • Approved
  • A D
    Tablet, film coated • 2 mg/1 • Oral • US • Generic • OTC • Approved
  • A D
    Tablet, film coated • 2 mg/1 • Oral • US • Generic • OTC • Approved
  • Alti-loperamide - 2mg Caplet
    Tablet • 2 mg • Oral • Canada • Generic • OTC • Approved
  • Amazon Basic Care Loperamide Hydrochloride
    Tablet • 2 mg/1 • Oral • US • Generic • OTC • Approved
  • Anti Diarrheal
    Solution • 1 mg/5mL • Oral • US • Generic • OTC • Approved
  • Anti Diarrheal
    Tablet • 2 mg/1 • Oral • US • Generic • OTC • Approved
Menampilkan 8 dari 489 produk.
International Brands
  • Dimor — Nordic Drugs
  • Fortasec — Esteve
  • Kaopectate II — Chattem, Inc.
  • Lopedium — Sandoz
  • Lopedium express — Sandoz
  • Lopex — Orion
  • Maalox Anti-Diarrheal — Novartis International AG
  • Pepto Diarrhea Control — Procter & Gamble

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul